Annabelle Fowler is a panelist during the session titled “Improving Sustainable Biomedical Innovation.”
For more information on this event, click here.
Beyond the single asset: The rise of combination and synergistic innovation in neurology drug development
Introduction Historically, drug development within the neurology space has been characterized by the search for individual therapies that can arrest complex...